NasdaqCM - Delayed Quote • USD
ZyVersa Therapeutics, Inc. (ZVSA)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 7:10 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -3.75 | -3.7 | -15.05 | -94.9 |
| Low Estimate | -5.3 | -5.8 | -22.7 | -185 |
| High Estimate | -2.2 | -1.6 | -7.4 | -4.8 |
| Year Ago EPS | -- | -31.5 | -1,089.7 | -15.05 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | |
|---|---|---|---|---|
| EPS Est. | -- | -56 | -21.4 | -3.7 |
| EPS Actual | -- | -31.5 | -136.8 | -4.53 |
| Difference | -- | 24.5 | -115.4 | -0.83 |
| Surprise % | -- | 43.80% | -539.30% | -22.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -3.75 | -3.7 | -15.05 | -94.9 |
| 7 Days Ago | -3.75 | -3.7 | -15.05 | -94.9 |
| 30 Days Ago | -0.37 | -0.37 | -1.5 | -9.49 |
| 60 Days Ago | -0.37 | -0.37 | -1.5 | -9.49 |
| 90 Days Ago | -1.46 | -1.35 | -5.75 | -9.49 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ZVSA | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 8.00% |
| Next Qtr. | 88.30% | -- | -- | 12.40% |
| Current Year | 98.60% | -- | -- | 5.60% |
| Next Year | -530.60% | -- | -- | 13.00% |
| Next 5 Years (per annum) | -- | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/29/2024 |
Related Tickers
SPRC SciSparc Ltd.
1.2200
+1.67%
VRAX Virax Biolabs Group Limited
0.8395
+4.94%
PXMD PaxMedica, Inc.
0.2401
-1.50%
CDIO Cardio Diagnostics Holdings, Inc.
0.7300
-12.99%
CMND Clearmind Medicine Inc.
1.2200
-5.43%
QNRX Quoin Pharmaceuticals, Ltd.
0.7600
-2.06%
REVB Revelation Biosciences, Inc.
2.0200
+8.60%
TCBP TC Biopharm (Holdings) Plc
1.1300
-0.88%
ELEV Elevation Oncology, Inc.
3.6100
0.00%
PALI Palisade Bio, Inc.
6.36
-1.55%